Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

Background There is limited experience with the use of argatroban in combination with glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitor in acute coronary syndrome (ACS) patients with heparin-induced thrombocytopenia (HIT) undergoing percutaneous coronary intervention (PCI). Materials and methods This sin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 2008-04, Vol.25 (2), p.214-218
Hauptverfasser:	Cruz-Gonzalez, Ignacio, Sanchez-Ledesma, Maria, Baron, Suzanne J., Healy, Josephine L., Watanabe, Hikari, Osakabe, Masanori, Yeh, Robert W., Jang, Ik-Kyung
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - complications Acute Coronary Syndrome - therapy Aged Aged, 80 and over Angioplasty, Balloon, Coronary Anticoagulants - adverse effects Cardiology Drug Therapy, Combination Female Hematology Heparin - adverse effects Humans Male Medicine Medicine & Public Health Middle Aged Pipecolic Acids - adverse effects Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Retrospective Studies Thrombocytopenia - chemically induced Thrombocytopenia - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!